| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 24.05.
| Perception, Opportunity in Volatility - Research & Analysis on Arena Pharmaceuticals, Inc. and DryShips Inc. | | 34 | MarketWire |
| HONG KONG -- (Marketwire) -- 05/24/12 -- This morning, www.MarketFoundations.com announced new reports highlighting Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and DryShips Inc. (NASDAQ: DRYS). Free...
Mehr lesen zu:
Perception, Opportunity in Volatility - Research & Analysis on Arena Pharmaceuticals, Inc. and DryShips Inc. | |
| 22.05.
| Institutional Investors Bet On Prolor, Synergy, Arena Pharmaceuticals | | 19 | Seeking Alpha |
| 21.05.
| Arena Pharma Announces Completion Of Public Offering Of Common Stock | | 90 | AFX News |
| WASHINGTON (dpa-AFX) - Arena Pharma, Inc. (ARNA) announced that it has
completed an underwritten public offering of 12.7 million shares of its common
stock, including 1.7 million shares...
Mehr lesen zu:
Arena Pharma Announces Completion Of Public Offering Of Common Stock | |
| 21.05.
| Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock | | 53 | PR Newswire |
| SAN DIEGO, May 21, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the completion of an underwritten public offering of 12,650,000 shares of its common stock, including...
Mehr lesen zu:
Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock | |
| 21.05.
| Post Earnings Update: Arena Pharmaceuticals Has Climbed 136.9% Higher in Past 2 Weeks | | 8 | SmarTrend |
| 16.05.
| Arena Pharma says it will sell 11M shares of stock | | 11 | Yahoo-USA |
| 16.05.
| Arena Pharmaceuticals and PowerShares QQQ Trust Among Most Active Stocks in Pre-Market Today on the Nasdaq | | 4 | Minyanville |
| 16.05.
| Critical Alerts For Research in Motion, Hess, Lions Gate, TRW Automotive, and Arena Pharmaceuticals Released By InvestorsObserver | | 58 | PR Newswire |
| CHICAGO, May 16, 2012 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for RIMM, HES, LGF, TRW, and ARNA.
To see what our analysts have discovered about these stocks read the InvestorsObserver's...
Mehr lesen zu:
Critical Alerts For Research in Motion, Hess, Lions Gate, TRW Automotive, and Arena Pharmaceuticals Released By InvestorsObserver | |
| 16.05.
| Arena Pharma Prices 11 Mln Shares Offering At $5.50/Shr | | 27 | AFX News |
| WASHINGTON (dpa-AFX) - Arena Pharmaceuticals Inc. (ARNA) said it has priced
an underwritten public offering of 11.0 million shares, at $5.50 per share. The
gross proceeds to Arena from this...
Mehr lesen zu:
Arena Pharma Prices 11 Mln Shares Offering At $5.50/Shr | |
| 16.05.
| Arena Pharmaceuticals (ARNA) Prices 11M Offering at $5.50/Share | | 1 | StreetInsider.com |
| 16.05.
| Arena Pharmaceuticals Prices Public Offering of Common Stock | | 22 | PR Newswire |
| SAN DIEGO, May 16, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock, offered...
Mehr lesen zu:
Arena Pharmaceuticals Prices Public Offering of Common Stock | |
| 16.05.
| Arena Pharma Plans Stock Offering | | 75 | AFX News |
| WASHINGTON (dpa-AFX) - Arena Pharmaceuticals, Inc. (ARNA) said Tuesday that
it plans to offer and sell shares of its common stock in an underwritten public
offering. There can be no assurance...
Mehr lesen zu:
Arena Pharma Plans Stock Offering | |
| 15.05.
| Arena Pharma says it plans new stock offering | | 6 | Yahoo-USA |
| 15.05.
| Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock | | 43 | PR Newswire |
| SAN DIEGO, May 15, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock...
Mehr lesen zu:
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock | |
| 14.05.
| Mulling Arena Pharma's Future With Obesity Drug on Approval Path | | 12 | The Street |
| 14.05.
| Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years / The Paragon Report Provides Stock Research on Arena Pharmaceuticals and Orexigen Therapeutics | | 51 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/14/12 -- Biotech companies are looking to cash in on the anti-obesity drug market. The race to bring the first weight-loss pill to the market is heating up as Arena...
Mehr lesen zu:
Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years / The Paragon Report Provides Stock Research on Arena Pharmaceuticals and Orexigen Therapeutics | |
| 13.05.
| Arena Pharmaceuticals: FDA Approval Is Just The Beginning | | 36 | Seeking Alpha |
| 11.05.
| Arena Pharmaceuticals up 63% on Positive FDA Panel Vote | | 25 | Benzinga.com |
| 11.05.
| Arena Pharmaceuticals Shares Climbing Higher, Up 72.7% | | 6 | SmarTrend |
| 11.05.
| Diet Pill Maker Arena Pharmaceuticals Wins Backing of FDA Advisers | | 12 | Minyanville |
